Why the study?
To elucidate how abnormal FHR proteins cause C3G by modeling CFHR5 nephropathy in mice.
Does adeno-associated virus vector-delivered homodimeric mini-FH reduce glomerular C3 deposition in a mouse model of CFHR5 nephropathy?
Does adeno-associated virus vector-delivered homodimeric mini-FH reduce glomerular C3 deposition in a mouse model of CFHR5 nephropathy?
Answers are grounded in this paper and cite their sources.
FHR5mut causes C3 glomerulopathy by disrupting complement regulation, and FH-derived molecules with enhanced C3 binding can reduce pathogenic C3 deposition.
gene generates a mutant FHR5 protein (FHR5mut) that leads to accumulation of complement C3 within glomeruli. To elucidate how abnormal FHR proteins cause C3G, we modeled CFHR5 nephropathy in mice. Animals lacking the murine factor H (FH) and FHR proteins, but coexpressing human FH and FHR5mut (hFH-FHR5mut), developed glomerular C3 deposition, whereas mice coexpressing human FH with the normal FHR5 protein (hFH-FHR5) did not. Like in patients, the FHR5mut had a dominant gain-of-function effect, and when administered in hFH-FHR5 mice, it triggered C3 deposition. Importantly, adeno-associated virus vector-delivered homodimeric mini-FH, a molecule with superior surface C3 binding compared to FH, reduced glomerular C3 deposition in the presence of the FHR5mut. Our data demonstrate that FHR5mut causes C3G by disrupting the homeostatic regulation of complement within the kidney and is directly pathogenic in C3G. These results support the use of FH-derived molecules with enhanced C3 binding for treating C3G associated with abnormal FHR proteins. They also suggest that targeting FHR5 represents a way to treat complement-mediated kidney injury.
No takes yet. Share an insight, caveat, or question.
Malik et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: